MicroRNA-34a is dispensable for p53 function as teratogenesis inducer

被引:0
|
作者
Eyal Mor
Lin He
Arkady Torchinsky
Noam Shomron
机构
[1] Tel-Aviv University,Sackler Faculty of Medicine
[2] University of California at Berkeley,Division of Cellular and Developmental Biology, Molecular and Cell Biology Department
来源
Archives of Toxicology | 2014年 / 88卷
关键词
miRNA; microRNA; miR-34; Limbs; Development; p53; Teratogens;
D O I
暂无
中图分类号
学科分类号
摘要
The tumor suppressor protein p53 is a powerful regulator of the embryo’s susceptibility to diverse teratogenic stimuli, functioning both as a teratogenesis inducer and suppressor. However, the targets that p53 engages to fulfill its functions remain largely undefined. We asked whether the microRNA (miRNA) miR-34 family, identified as one of the main targets of p53, mediates its function as a teratogenesis inducer. For this, pregnant ICR-, p53- and miR-34a-deficient mice, as well as rats, were exposed to 5-aza-2′-deoxycytidine (5-aza), a teratogen inducing limb reduction anomalies (LRA) of the hindlimbs in mice and either the hindlimbs or forelimbs in rats. Using hind- and forelimb buds of 5-aza-exposed embryos, we identified that the miR-34 family members are the most upregulated miRNAs in mouse and rat limb buds, with their increase level being significantly higher in limb buds destined for LRA. We showed that p53 mediates the 5-aza-induced miR-34 transcription followed by met proto-oncogene and growth-arrest-specific 1 target suppression in embryonic limb buds. We demonstrated that p53 regulates the teratogenic response to 5-aza acting as a teratogenesis inducer albeit miR-34a deletion does not affect the susceptibility of mice to 5-aza. Overall, our study thoroughly characterizes the expression and regulation of miR-34 family in teratogen-resistant and teratogen-sensitive embryonic structures and discusses the involvement of epigenetic miRNA-mediated pathway(s) in induced teratogenesis.
引用
收藏
页码:1749 / 1763
页数:14
相关论文
共 50 条
  • [41] The p53/microRNA connection in gastrointestinal cancer
    Rokavec, Matjaz
    Li, Huihui
    Jiang, Longchang
    Hermeking, Heiko
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2014, 7 : 395 - 413
  • [42] MicroRNA - Another piece in the p53 puzzle
    Seton-Rogers, Sarah
    NATURE REVIEWS CANCER, 2007, 7 (07) : 488 - 488
  • [43] The p53 Pathway Encounters the MicroRNA World
    Takwi, Apana
    Li, Yong
    CURRENT GENOMICS, 2009, 10 (03) : 194 - 197
  • [44] P53 FUNCTION AND DYSFUNCTION
    PIETENPOL, J
    VOGELSTEIN, B
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 163 - 163
  • [45] Speckle function for p53
    Zlotorynski, Eytan
    NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2021, 22 (06) : 372 - 372
  • [46] Regulation of p53 function
    Phillip, A
    Bates, S
    Kubbutat, M
    Ludwig, R
    Clarke, P
    Stott, F
    Peters, G
    Vousden, K
    BRITISH JOURNAL OF CANCER, 1999, 81 (04) : 565 - 566
  • [47] Regulation of p53 function
    Woods, DB
    Vousden, KH
    EXPERIMENTAL CELL RESEARCH, 2001, 264 (01) : 56 - 66
  • [48] Falling p53 function
    Sarah Seton-Rogers
    Nature Reviews Cancer, 2007, 7 : 811 - 811
  • [49] 17p13/TP53 deletion in B-CLL patients is associated with microRNA-34a downregulation
    Dijkstra, M. K.
    van Lom, K.
    Tielemans, D.
    Elstrodt, F.
    Langerak, A. W.
    van't Veer, M. B.
    Jongen-Lavrencic, M.
    LEUKEMIA, 2009, 23 (03) : 625 - 627
  • [50] TP53-mediated human cancer susceptibility is defined by epigenetic dysregulation of microRNA-34A
    Samuel, Nardin
    Wilson, Gavin
    Deblois, Genevieve
    Said, Badr Id
    Fischer, Nicholas W.
    Lemire, Mathieu
    Lou, Youliang
    Li, Weili
    Alexandrova, Roumiana
    Novokmet, Ana
    Tran, James
    Nichols, Kim E.
    Finlay, Jonathan L.
    Choufani, Sanaa
    Remke, Marc
    Ramaswamy, Vijay
    Cavalli, Florence M. G.
    Elser, Christine
    Meister, Lynn
    Taylor, Michael D.
    Tabori, Uri
    Irwin, Meredith
    Weksberg, Rosanna
    Wasserman, Jonathan D.
    Gariepy, Jean
    Lupien, Mathieu
    Merico, Daniele
    Paterson, Andrew
    Hansford, Jordan R.
    Achatz, Maria Isabel W.
    Hudson, Thomas J.
    Malkin, David
    CANCER RESEARCH, 2017, 77